Cargando…

Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank

BACKGROUND: Many different combinations of available data have been used to identify gout cases in large genetic studies. The aim of this study was to determine the performance of case definitions of gout using the limited items available in multipurpose cohorts for population-based genetic studies....

Descripción completa

Detalles Bibliográficos
Autores principales: Cadzow, Murray, Merriman, Tony R., Dalbeth, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551011/
https://www.ncbi.nlm.nih.gov/pubmed/28793914
http://dx.doi.org/10.1186/s13075-017-1390-1
_version_ 1783256228612276224
author Cadzow, Murray
Merriman, Tony R.
Dalbeth, Nicola
author_facet Cadzow, Murray
Merriman, Tony R.
Dalbeth, Nicola
author_sort Cadzow, Murray
collection PubMed
description BACKGROUND: Many different combinations of available data have been used to identify gout cases in large genetic studies. The aim of this study was to determine the performance of case definitions of gout using the limited items available in multipurpose cohorts for population-based genetic studies. METHODS: This research was conducted using the UK Biobank Resource. Data, including genome-wide genotypes, were available for 105,421 European participants aged 40–69 years without kidney disease. Gout definitions and combinations of these definitions were identified from previous epidemiological studies. These definitions were tested for association with 30 urate-associated single-nucleotide polymorphisms (SNPs) by logistic regression, adjusted for age, sex, waist circumference, and ratio of waist circumference to height. Heritability estimates under an additive model were generated using GCTA version 1.26.0 and PLINK version 1.90b3.32 by partitioning the genome. RESULTS: There were 2066 (1.96%) cases defined by self-report of gout, 1652 (1.57%) defined by urate-lowering therapy (ULT) use, 382 (0.36%) defined by hospital diagnosis, 1861 (1.76%) defined by hospital diagnosis or gout-specific medications and 2295 (2.18%) defined by self-report of gout or ULT use. Association with gout at experiment-wide significance (P < 0.0017) was observed for 13 SNPs with gout using the self-report of gout or ULT use definition, 12 SNPs using the self-report of gout definition, 11 SNPs using the hospital diagnosis or gout-specific medication definition, 10 SNPs using ULT use definition and 3 SNPs using hospital diagnosis definition. Heritability estimates ranged from 0.282 to 0.308 for all definitions except hospital diagnosis (0.236). CONCLUSIONS: Of the limited items available in multipurpose cohorts, the case definition of self-report of gout or ULT use has high sensitivity and precision for detecting association in genetic epidemiological studies of gout.
format Online
Article
Text
id pubmed-5551011
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55510112017-08-14 Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank Cadzow, Murray Merriman, Tony R. Dalbeth, Nicola Arthritis Res Ther Research Article BACKGROUND: Many different combinations of available data have been used to identify gout cases in large genetic studies. The aim of this study was to determine the performance of case definitions of gout using the limited items available in multipurpose cohorts for population-based genetic studies. METHODS: This research was conducted using the UK Biobank Resource. Data, including genome-wide genotypes, were available for 105,421 European participants aged 40–69 years without kidney disease. Gout definitions and combinations of these definitions were identified from previous epidemiological studies. These definitions were tested for association with 30 urate-associated single-nucleotide polymorphisms (SNPs) by logistic regression, adjusted for age, sex, waist circumference, and ratio of waist circumference to height. Heritability estimates under an additive model were generated using GCTA version 1.26.0 and PLINK version 1.90b3.32 by partitioning the genome. RESULTS: There were 2066 (1.96%) cases defined by self-report of gout, 1652 (1.57%) defined by urate-lowering therapy (ULT) use, 382 (0.36%) defined by hospital diagnosis, 1861 (1.76%) defined by hospital diagnosis or gout-specific medications and 2295 (2.18%) defined by self-report of gout or ULT use. Association with gout at experiment-wide significance (P < 0.0017) was observed for 13 SNPs with gout using the self-report of gout or ULT use definition, 12 SNPs using the self-report of gout definition, 11 SNPs using the hospital diagnosis or gout-specific medication definition, 10 SNPs using ULT use definition and 3 SNPs using hospital diagnosis definition. Heritability estimates ranged from 0.282 to 0.308 for all definitions except hospital diagnosis (0.236). CONCLUSIONS: Of the limited items available in multipurpose cohorts, the case definition of self-report of gout or ULT use has high sensitivity and precision for detecting association in genetic epidemiological studies of gout. BioMed Central 2017-08-09 2017 /pmc/articles/PMC5551011/ /pubmed/28793914 http://dx.doi.org/10.1186/s13075-017-1390-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Cadzow, Murray
Merriman, Tony R.
Dalbeth, Nicola
Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
title Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
title_full Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
title_fullStr Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
title_full_unstemmed Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
title_short Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
title_sort performance of gout definitions for genetic epidemiological studies: analysis of uk biobank
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551011/
https://www.ncbi.nlm.nih.gov/pubmed/28793914
http://dx.doi.org/10.1186/s13075-017-1390-1
work_keys_str_mv AT cadzowmurray performanceofgoutdefinitionsforgeneticepidemiologicalstudiesanalysisofukbiobank
AT merrimantonyr performanceofgoutdefinitionsforgeneticepidemiologicalstudiesanalysisofukbiobank
AT dalbethnicola performanceofgoutdefinitionsforgeneticepidemiologicalstudiesanalysisofukbiobank